| Triazolo [4, 5-D] pyrimidines U Grether, M Nettekoven, M Rogers-Evans, S Schmitt, BJ Stenton US Patent App. 10/183,946, 2019 | 235* | 2019 |
| A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging BJ Stenton, BL Oliveira, MJ Matos, L Sinatra, GJL Bernardes Chemical Science 9 (17), 4185-4189, 2018 | 86 | 2018 |
| Platinum-triggered Bond-cleavage of Pentynoyl amide and N-propargyl handles for Drug-Activation BL Oliveira, BJ Stenton, CR de Almeida, J Conde, M Negrão, ... Journal of the American Chemical Society, 2020 | 84 | 2020 |
| Bioorthogonal Decaging Reactions for Targeted Drug Activation S Davies, BJ Stenton, GJL Bernardes CHIMIA International Journal for Chemistry 72 (11), 771-776, 2018 | 22 | 2018 |
| Triazolo [4, 5-D] pyrimidines U Grether, M Nettekoven, M Rogers-evans, S Schmitt, BJ Stenton US Patent App. 15/478,435, 2019 | 4 | 2019 |
| Novel triazolo [4, 5-d] pyrimidines U Grether, M Nettekoven, M Rogers-Evans, S Schmitt, BJ Stenton US Patent App. 15/478,435, 2017 | 4* | 2017 |
| Cisplatin-Triggered Bioorthogonal Decaging of Amide Bonds for Targeted-Drug Activation in vivo B Stenton, B Oliveira, J Conde, M Negrão, MG Ferreira, R Fior, ... ChemRxiv, 2018 | 2 | 2018 |
| Metal mediated mechanisms of drug release BJ Stenton University of Cambridge, 2018 | | 2018 |
